TME Pharma fait le point sur ses activités
Filed with Euronext · · 4 pages · French
Earlier from TME Pharma
- Minutes of the TME Pharma Annual General Meeting
- Compte-rendu de l’assemblée générale de TME Pharma
- TME Pharma announces convocation of the 2026 annual general meeting of shareholders
- TME Pharma publishes its annual financial results and annual report
- TME Pharma Announces Publication of NOX-A12 “Triple Therapy” Phase 1/2 Expansion Arm A Findings from GLORIA trial in Nature Communications
Later from TME Pharma
- Message du CEO de TME Pharma
- TME Pharma CEO message
- TME Pharma extends financial visibility by lengthening debt maturity to June 2028
- TME Pharma Signs Binding Exclusive Negotiation Agreement with Japanese TMS Co., Ltd.
- TME Pharma Publishes Its Semi Annual Results and Half-Year Report
Follow TME Pharma into a list and get an email when it puts out news.
Follow TME Pharma